The synchronous occurrence of GIST and other primary gastrointestinal malignancies has been rarely reported. We report the case of an 84 year-old female who presented with a rectal blood loss. Total coloscopy revealed a stenotic lesion at sigmoid colon covered by endoscopically healthy mucosa and also a massive polypoid cecal mass. The patient underwent left subtotal colectomy and ileorectal J-pouch anastomoses without diverting stoma. Histologically the sigmoid tumor met the GIST criteria and the cecal mass was a well differentiated adenocarcinoma. To our knowledge this synchronous occurrence is reported for first time in the literature.
INTRODUCTION
Gastrointestinal stromal tumors (Gist's) have only recently become recognized as a distinct pathologic entity. the term was first used in 1983 by Mazur and Clark to encompass gastrointestinal and mesenteric non-epithelial neoplasms that lacked the immunohistochemical features of schwann cells and did not have the ultrastructural characteristics of smooth muscle cells.
1 the vast majority of Gist's are positive for CD117 and vimentin in immunohistochemical staining. [2] [3] [4] their epidemiology still remain incompletely known. With an annual incidence rainging between 6.8 and 14.5 cases per million and an estimated 5-year survival rate of 45-65%, Gist's typically present in older individuals and are most common in the stomach (60%), followed by small intestine (15%), colon and rectum (5%), esophagus, mesentery and omentum 5, 6 .
the synchronous occurrence of Gist and other primary gastrointestinal malignancies has been rarely reported. in these cases stomach and small intestine were the most common locations for the Gist. [7] [8] [9] [10] [11] in the present case report we describe a 84 year-old woman with Gist of sigmoid colon and synchronous invasive adenocarcinoma at the ileocecal valve. to our knowledge, this synchronous occurrence has not been reported in the literature.
CASE REPORT
a 84 year-old Caucasian female, with a recently diagnosed Gist, located in the colon, was admitted to the Gastroenterology department of "agios savvas" Cancer Hospital, athens, Greece, in February 2007. a lower gastrointestinal tract endoscopic examination, performed a month before due to rectal blood loss, was stopped in the sigmoid colon area because of a great stenosis. tissue specimens obtained endoscopically from the stenosis were stained positive for CD117, CD34 and vimentin. the patient's past medical history included hypertension, atrial fibrillation and alzheimer disease. No history of malignancy was noted in her family history. Physical and rectal digital examination were undiagnostic.
Complete blood count, urine tests, standard biochemical studies and also serum levels of tumor markers including CEa, Ca 19-9, aFP, Ca125 and Ca 15-3 were within normal ranges.
Chest X-ray and upper abdominal ultrasonography were normal. abdominal computed tomography showed wall thickening of ascending colon and cecum in a length of more than 7 cm. total colonoscopy revealed the already known stenosis at sigmoid colon, covered by endoscopically normal mucosa and also a massive polypoid mass (diameter almost 5cm) in ascending colon, close to the ileocecal valve.
Multiple biopsies were obtained with conventional biopsy forceps from the cecal lesion. Histology revealed mild/moderate dysplastic alterations from a mixed type (hyperplastic-adenomatous) colonic polyp.
the patient underwent left subtotal colectomy and ileorectal J-pouch anastomosis without diverting stoma 10 days after.
PATHOlOGY REPORT
Pathology department was examined three surgical specimens. the first one (total length 60 cm), consisted of a 7 cm lenth portion of small intestine adjoining by the ileocecal valve, the cecum and a portion of large intestine. Grossly, was observed a 5x5 cm cecal papillary mass close to the ileocecal valve with intracanalicular growth. Histology revealed a well differentiated adenocarcinoma limited to the muscularis propria, stage Dukes a and B1. None of the twelve examined lymph nodes presented metastatic invasion. the second (8 cm, large intestine) was without macroscopic alterations.
Gross examination of the third specimen revealed, 8 cm from the distal surgical margin, a 2,8x2,5x2 cm mass producing from the outer muscularis propria to the mucosa with a small ulceration and central cystic degeneration filled with blood. Histologically, the tumor demonstrated a mixed cell type appearance of a) epithelioid and b) uniform spindle cells (Fig. 1) which stained positive for CD 117 (Kit) (Fig. 2) and CD 34, slight positive for sMa and negative for vimentin, s-100 and desmin, with a mitotic activity <3 per 50 high power fields (HPF). None of the 12 lymph nodes recovered from the specimen showed evidence of metastatic disease. the final pathological diagnosis of this tumor was Gist of low grade malignancy with no metastatic involvement.
DISCUSSION
at present, Gist's may be defined as morphologically spindle cell, epitheloid, or occasionally pleomorphic, mesenchymal tumors, originated from interstitial cells of Cajal or related stem cells, that usually express the Kit protein (-95%) and, that often harbour mutation of a gene that encodes for a type iii receptor tyrosine kinase. [12] [13] [14] although they are the commonest gastrointestinal soft tissue tumors and can originate anywhere in the digestive tract, colon Gist's are relatively infrequent. 8, 15 on the other hand, the synchronous occurrence of Gist's and other primary gastrointestinal malignancies has been rarely reported in the literature.
7-11,16-22 the vast majority of these synchronous tumors are adenocarcinomas. 9 to the best of our knowledge, the synchronous occurrence of two independent malignancies of colon, a Gist and an adenocarcinoma, has never been reported. the most important manifestation of stromal tumors is their indolent, slow growing nature. they are generally found within the deeper stroma and the submucosa, and are often incidentally discovered during imaging studies. symptomatic lesions have manifestation that depend on tumor size, location and growth pattern. [23] [24] [25] tumors less than 2 cm are generally asymptomatic while tumors with diameter more than 4 cm are associated with symptomatic disease. 26 Bleeding is the most common symptom at presentation and may take place either into abdominal cavity or into gastrointestinal tract lumen, as in the present case 27 . localized Gist's risk assessment profile, according to the NiH consensus report of 2002, is based on the primary tumor diameter and the mitotic count. thus, a mitotic index over 5 per 50 HPF or size more than 5 cm are considered as unfavorable prognostic factors. 28 surgery is the standard of care for primary, localized, non-metastatic disease and provide 5-year survival rates ranging between 45% and 65%. 4, 29, 30 imatinib, a tyrosine kinase inhibitor, is widely used in the treatment of advanced and metastatic Gist's and has been recently employed in the neo adjuvant and adjuvant set-up with encouraging results. another therapeutic agent, sutinib, is approved for the treatment of imatinib-resistant tumors and a large spectrum of new small molecule inhibitors are in the pipeline eg. nilotinib, everolimus. [31] [32] [33] [34] 
